Eichenberger Patrick M, Lampert Markus L, Kahmann Irene Vogel, van Mil J W Foppe, Hersberger Kurt E
Pharmaceutical Care Research Group, University of Basel, Pharmazentrum, Klingelbergstrasse 50, 4056, Basel, Switzerland.
Pharm World Sci. 2010 Jun;32(3):362-72. doi: 10.1007/s11096-010-9377-x. Epub 2010 Mar 13.
To explore and classify drug-related problems (DRPs) with new prescriptions detected in community pharmacies using a modified PCNE (Pharmaceutical Care Network Europe) classification system.
Sixty-four Swiss community pharmacies offering internships for pharmacy students.
Occurrence, nature and pharmacist's management of DRPs.
Fifth-year pharmacy students collected consecutively hospital discharge and primary care prescriptions. After training, they documented clinical and technical DRPs, causes and interventions.
Prescriptions of 616 patients (43.0% discharged from hospital) were analysed. The patients' median age was 56 years and they received a median of 3 (range 2-19) different drugs. In 121 (19.6%) prescriptions 141 clinical DRPs were detected. The most frequent clinical DRPs were potential drug-drug interactions (DDIs) (37.6%), drug choice (24.8%) and drug use problems (15.6%). These clinical DRPs led to a total of 299 interventions. There were 222 prescriptions (36.0%) that showed 278 technical DRPs, resulting in a total of 417 interventions. Most frequent technical DRPs were missing or unclear package size or therapy duration (32.7%) and missing or unclear dosing/application instructions (30.9%). Most DRPs (75.4%) could be managed by the pharmacist alone. The number of prescribed drugs was the main factor with an influence on the frequency of clinical and technical DRPs.
Clinical and technical DRPs are frequently observed in primary care as well as in hospital discharge prescriptions. The modified PCNE classification system, especially the amendment with a technical DRP category, proved to be useful and allowed the classification of all DRPs. Neither the setting (hospital discharge vs. primary care) nor the quality of electronically printed prescriptions, but only the number of prescribed drugs influenced the occurrence of clinical or technical DRPs.
使用改良的欧洲药学服务网络(PCNE)分类系统,对社区药房新处方中发现的药物相关问题(DRP)进行探索和分类。
64家为药学专业学生提供实习机会的瑞士社区药房。
DRP的发生率、性质及药剂师的处理情况。
五年级药学专业学生连续收集医院出院处方和初级保健处方。经过培训后,他们记录临床和技术方面的DRP、原因及干预措施。
分析了616例患者的处方(43.0%为出院患者)。患者的年龄中位数为56岁,平均每人接受3种(范围为2 - 19种)不同药物治疗。在121份(19.6%)处方中检测到141个临床DRP。最常见的临床DRP是潜在药物相互作用(DDI)(37.6%)、药物选择(24.8%)和用药问题(15.6%)。这些临床DRP共导致299次干预措施。有222份(36.0%)处方存在278个技术DRP,共导致417次干预措施。最常见的技术DRP是包装规格或治疗疗程缺失或不明确(32.7%)以及给药/应用说明缺失或不明确(30.9%)。大多数DRP(75.4%)可由药剂师单独处理。处方药物数量是影响临床和技术DRP发生频率的主要因素。
在初级保健以及医院出院处方中经常观察到临床和技术DRP。改良的PCNE分类系统,特别是增加了技术DRP类别,证明是有用的,能够对所有DRP进行分类。无论是处方来源(医院出院处方还是初级保健处方)还是电子打印处方的质量,都不会影响临床或技术DRP的发生,只有处方药物数量会产生影响。